Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: OrganiGram Holdings Inc

Market Cap 194M 137M 119M 111M 104M 12.93B 195M 1.31B 509M 6.36B 514M 503M 22.1B P/E 2026 *
10.6x
P/E 2027 * 34.5x
Enterprise Value 194M 137M 119M 111M 104M 12.93B 195M 1.31B 509M 6.36B 514M 503M 22.1B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.44x
Free-Float
69.76%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 137M
+72.76%-.--%-39.25% - 578M
+3.12%-2.94%+25.00%+83.33% 115M
0.00%-1.89%+79.31%-18.75% 106M
+3.29%+0.78%+73.91%-4.84% 95.86M
Average +16.78%-1.97%+34.74%+19.92% 223.55M
Weighted average by Cap. +42.05%-0.93%-4.87%+22.56%

Financials

2026 *2027 *
Net sales 340M 240M 209M 193M 181M 22.6B 342M 2.29B 889M 11.12B 899M 880M 38.63B 441M 311M 271M 251M 235M 29.34B 443M 2.98B 1.15B 14.44B 1.17B 1.14B 50.14B
Net income 18.88M 13.31M 11.61M 10.75M 10.07M 1.26B 18.99M 128M 49.43M 618M 49.98M 48.91M 2.15B 6.53M 4.61M 4.02M 3.72M 3.48M 435M 6.57M 44.13M 17.1M 214M 17.29M 16.92M 743M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!